Swiss pleasure cruiser turned into vaccine 'shot ship' for lakeside towns | Inquirer News

Swiss pleasure cruiser turned into vaccine ‘shot ship’ for lakeside towns

/ 03:44 PM February 03, 2021

ROMANSHORN, Switzerland — An 89-year-old passenger ship, out of commission due to the coronavirus pandemic, was re-purposed on Tuesday as a COVID-19 vaccination centre for thousands of residents from cities on Lake Constance.

The 500-passenger MS Thurgau normally carries tourists and commuters between German and Swiss cities on Europe’s third-largest lake. In the coming weeks it will serve as a floating inoculation hub for northern Swiss towns Romanshorn, Arbon and Kreuzlingen.

Regional officials emphasized the ship’s practicality since it can sail from harbor to harbor, earning it the nickname “vaccine vaporetto” with some locals.

ADVERTISEMENT

“I’ve heard of a fondue ship, and a spaghetti ship, but this is my first shot ship,” Switzerland’s Health Minister Alain Berset told reporters just after the first people to be vaccinated walked the gangway.

FEATURED STORIES

Switzerland reported just over 1,600 new infections on Tuesday, bringing its total to 526,000, with the cases of fast-spreading variants doubling every week. Nearly 8,800 people have died.

Aboard MS Thurgau there are two shot stations capable of vaccinating 24 people per hour – one every five minutes – or 168 people daily during a seven-hour shift.

As more vaccines arrive in Switzerland, stations can be expanded to eight.

For the first week, the ship will be in Romanshorn, a historic lakeside grain trading centre, followed by two weeks in larger Kreuzlingen.

After another week in nearby Arbon, the vessel will make the return voyage to Romanshorn, so those inoculated earlier can get a required booster shot.

“It was perfectly organized. I didn’t even feel the needle,” said Kurt Huber, who lives in the region, as he disembarked from the gangway after his shot. He said he would recommend the shot ship to others who might be hesitating over whether to be vaccinated.

ADVERTISEMENT

“When you see what otherwise could happen, it’s simply logical,” he said.

Only Moderna shots are being used aboard the MS Thurgau, since the 10-dose vials are slightly easier to prepare in the ship’s cramped quarters, medics said.

The canton of Thurgau initially considered creating vaccine centers aboard buses, but eventually opted for the idled pleasure cruiser.

“We wanted to figure out just how we could vaccinate as many people as possible, with as few vaccination centers as were necessary,” said Urs Martin, a Thurgau elected official.

Like elsewhere in Europe, the tourism-reliant Lake Constance region has been broadsided by the pandemic.

A border fence temporarily erected between adjacent towns of Constance, Germany, and Kreuzlingen, Switzerland, last year divided families, friends and lovers for weeks.

The initial round of shots aboard the MS Thurgau is planned for the next 12 weeks, said Adriano Mari, leader for all of Thurgau’s vaccination centers run by private hospital group Hirslanden, a unit of South Africa-based Mediclinic.

He hopes an extension beyond this maiden voyage won’t be necessary.

“Hopefully by then, things will have eased and the ship can return to carrying passengers on its regular route,” Mari said.

Your subscription could not be saved. Please try again.
Your subscription has been successful.

Subscribe to our daily newsletter

By providing an email address. I agree to the Terms of Use and acknowledge that I have read the Privacy Policy.

($1 = 0.8977 Swiss francs)

For more news about the novel coronavirus click here.
What you need to know about Coronavirus.
For more information on COVID-19, call the DOH Hotline: (02) 86517800 local 1149/1150.

The Inquirer Foundation supports our healthcare frontliners and is still accepting cash donations to be deposited at Banco de Oro (BDO) current account #007960018860 or donate through PayMaya using this link.

TAGS: Coronavirus, COVID-19, COVID-19 Vaccine, Switzerland

© Copyright 1997-2024 INQUIRER.net | All Rights Reserved

We use cookies to ensure you get the best experience on our website. By continuing, you are agreeing to our use of cookies. To find out more, please click this link.